IINN
Inspira Technologies OXY B.H.N. Ltd
$0.3751
-1.30%
No data for this timeframe.
Vol
Press Releases11
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. L3·CIK 0001837493·Prev Close $0.3800
Recent Activity
May 21, 2026
contract
QTREX in Advanced Discussions with Top-Five Global Quantum Computing Company Regarding Strategic Collaboration
<p>Nes Ziona, Israel, May 21, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX"
May 18, 2026
Press
Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100
Impact 5/10
May 11, 2026
Press
Inspira Technologies issued a shareholder letter outlining a strategic pivot into quantum connectivity and AME, reportin
Impact 5/10
Price Targets
Historical data — last covering-analyst action Jun 2025. No current recommendation available.
$5.00 (Jun 2025)
Current $0.3800
Low $5.00
Median $5.00
High $5.00
1 analysts
$5.00
$5.00
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 2, 2025 | Litchfield Hills | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $0.10 ▼ -9.1% | $0.10 — $0.10 | 122% YoY | 1 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
BULLISH
5/10
Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its
May 18, 2026
NEUTRAL
5/10
Inspira Technologies issued a shareholder letter outlining a strategic pivot into quantum connectivi
May 11, 2026
NEUTRAL
4/10
Inspira Technologies secured a $596,000 purchase order for its AME system from a leading Irish techn
May 1, 2026
BULLISH
6/10
Inspira Technologies announced the successful delivery and acceptance of its Additively Manufactured
Apr 16, 2026
NEUTRAL
3/10
Inspira Technologies announced the appointment of Yoav Rozanovich as Chief Business Officer to lead
Apr 14, 2026
MIXED
5/10
Inspira Technologies announced the commencement of an AME technology implementation with one of the
Apr 13, 2026
NEUTRAL
4/10
Inspira Technologies (IINN) announced a strategic pivot into the quantum computing sector, leveragin
Apr 6, 2026
BULLISH
7/10
Inspira Technologies acquired Nano Dimension's AME platform for up to $12.5 million, including $2 mi
Apr 6, 2026
NEUTRAL
3/10
Inspira Technologies terminated its sales agreement with A.G.P. and its Standby Equity Purchase Agre
Mar 31, 2026
MIXED
6/10
Inspira Technologies reported minimal revenue of $289,000 in 2025 with a net loss of $13.22 million,
Mar 26, 2026
NEUTRAL
4/10
Inspira Technologies announced the deployment of its FDA-cleared ART100 system at a top-ranked acade
Feb 26, 2026
Historical analyst distribution (last covering-analyst action Jun 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jun 2025. No current recommendation available.
$5.00 mean target (Jun 2025)
$5.00 Low
$5.00 High
| Metric | Value |
|---|---|
| Current Price | $0.3800 |
| Target Low | $5.00 |
| Target Mean | $5.00 |
| Target Median | $5.00 |
| Target High | $5.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.10 | $0.10 | $0.10 | 122.2% | -9.1% | 1↑ 0↓ | $0.0B | 16509.0% | 1 |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 2, 2025 | Litchfield Hills | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 21, 2026
contract
QTREX in Advanced Discussions with Top-Five Global Quantum Computing Company Regarding Strategic Collaboration
<p>Nes Ziona, Israel, May 21, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a developer of additively manufa
May 18, 2026
contract
NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation
<p>RA'ANANA, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today
May 11, 2026
contract
Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan
<p>RA'ANANA, Israel, May 11, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira," "Inspira Technologies,
May 1, 2026
contract
Inspira Secures $596,000 AME System Order from Leading Irish Technological University
<p>RA'ANANA, Israel, May 01, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today
Apr 30, 2026
contract
Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems
<p>RA'ANANA, Israel, April 30, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN<b>)</b> ("Inspira" or the "Company") toda
Apr 16, 2026
contract
Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity
<p>RA'ANANA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), today ann
Apr 14, 2026
contract
Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion
<p>RA'ANANA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd (NASDAQ: IINN, IINNW) (“Inspira Technologies” or the “Co
Apr 13, 2026
contract
Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies
<p>RA'ANANA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- <b>Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) </b>("Inspira" or the "Company"), to
Apr 6, 2026
contract
Inspira Enters Quantum Computing Sector, Targeting a Critical Connectivity Bottleneck with Newly Acquired AME Platform
<p>RA'ANANA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (“Inspira” or the “Company”) today ann
Apr 6, 2026
contract
Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension
<p align="center"><i>The transaction includes intellectual property</i><i>,</i> <i>customer-related assets and commercial operations, positioning the
Mar 31, 2026
announcement
Inspira Technologies Terminates ATM and SEPA Equity Facilities to Prepare for Next Strategic Phase
<p>RA'ANANA, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer
Mar 26, 2026
earnings
Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates
Company Demonstrates Clinical Validation and Early Commercial Traction Toward 2026 Revenue Scale <pre>Company Demonstrates Clinical Validation and Ear
Mar 11, 2026
earnings_calendar
IINN Q4 2025 Earnings Scheduled — 2026-03-11
Feb 18, 2026
contract
Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State
<p>RA'ANANA, Israel, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) (“Inspira Technologies” or t